Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
NCT ID: NCT04472039
Last Updated: 2020-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-06-30
2020-09-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Choroidal Thickness Vitrectomy
NCT02617147
New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes
NCT06948851
Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling
NCT03457584
Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes
NCT06459284
"Cataract Surgery in Eyes With Epiretinal Membrane"
NCT03404323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Studygroup
Retrospective analysis of OCT, IOP and distance corrected visual acuity from the patients history.
optical coherence tomography (OCT)
OCT visualizes the retinal layers by backreflection of light
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
optical coherence tomography (OCT)
OCT visualizes the retinal layers by backreflection of light
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* indication for membrane peeling defined as significant loss of vision and/or metamorphopsia due to the ERM
* application of periocular triamcinolone acetonide at the end of surgery
* at least one follow-up examination present in the patient's history
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vienna Institute for Research in Ocular Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Prof. Dr. Oliver Findl, MBA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Findl, Prof.
Role: PRINCIPAL_INVESTIGATOR
Vienna Institute for Research in Ocular Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.